 |
|
NUDT15 gene variants and thiopurine-induced leukopenia in patients with inflammatory bowel disease
Katsuyoshi Matsuoka
Intest Res. 2020;18(3):275-281. Published online 2020 Jun 3 DOI: https://doi.org/10.5217/ir.2020.00002
|
|
Citations to this article as recorded by
 Determination of Deleterious SNPs in NUDT15 Gene Related to Acute Lymphoblastic Leukemia by using Bioinformatics Tools
Deniz AŞLAR ÖNER
İstanbul Gelişim Üniversitesi Sağlık Bilimleri Dergisi.2024; (21): 866. CrossRef Real-world NUDT15 genotyping and thiopurine treatment optimization in inflammatory bowel disease: a multicenter study
Motoki Makuuchi, Yoichi Kakuta, Junji Umeno, Toshimitsu Fujii, Tetsuya Takagawa, Takashi Ibuka, Miki Miura, Yu Sasaki, Sakuma Takahashi, Hiroshi Nakase, Hiroki Kiyohara, Keiichi Tominaga, Yosuke Shimodaira, Sakiko Hiraoka, Nobuhiro Ueno, Shunichi Yanai, T
Journal of Gastroenterology.2024;[Epub] CrossRef Concomitant pharmacologic medications influence the clinical outcomes of granulocyte and monocyte adsorptive apheresis in patients with ulcerative colitis: A multicenter retrospective cohort study
Nobuhiro Ueno, Yuya Sugiyama, Yu Kobayashi, Yuki Murakami, Takuya Iwama, Takahiro Sasaki, Takehito Kunogi, Aki Sakatani, Keitaro Takahashi, Kazuyuki Tanaka, Shinya Serikawa, Katsuyoshi Ando, Shin Kashima, Momotaro Muto, Yuhei Inaba, Kentaro Moriichi, Hiro
Journal of Clinical Apheresis.2023; 38(4): 406. CrossRef Treatment of Autoimmune Hepatitis
Ja Kyung Kim
The Korean Journal of Gastroenterology.2023; 81(2): 72. CrossRef Molecular medicine-based IBD treatment strategies—we take it personally!
Viktoria Hentschel, Jochen Klaus
Frontiers in Gastroenterology.2023;[Epub] CrossRef KASL clinical practice guidelines for management of autoimmune hepatitis 2022
Clinical and Molecular Hepatology.2023; 29(3): 542. CrossRef Nucleoside-based anticancer drugs: Mechanism of action and drug resistance
Lenka Hruba, Viswanath Das, Marian Hajduch, Petr Dzubak
Biochemical Pharmacology.2023; 215: 115741. CrossRef Comparative assessment of anti-cancer drugs against NUDT15 variants to prevent leucopenia side effect in leukemia patients
V. Janakiraman, M. Sudhan, Khalaf F. Alsharif, Ibrahim F. Halawani, Shiek S.S.J. Ahmed, Shankargouda Patil
Journal of Genetic Engineering and Biotechnology.2023; 21(1): 82. CrossRef Inflammatory Bowel Disease: Pathophysiology, Treatment, and Disease Modeling
Jiryeon Jang, Sehoon Jeong
BioChip Journal.2023; 17(4): 403. CrossRef Use of thiopurines in inflammatory bowel disease: an update
Arshdeep Singh, Ramit Mahajan, Saurabh Kedia, Amit Kumar Dutta, Abhinav Anand, Charles N. Bernstein, Devendra Desai, C. Ganesh Pai, Govind Makharia, Harsh Vardhan Tevethia, Joyce WY Mak, Kirandeep Kaur, Kiran Peddi, Mukesh Kumar Ranjan, Perttu Arkkila, Ra
Intestinal Research.2022; 20(1): 11. CrossRef Long-term efficacy and tolerability of dose-adjusted thiopurine treatment in maintaining remission in inflammatory bowel disease patients with NUDT15 heterozygosity
Takato Maeda, Hirotake Sakuraba, Hiroto Hiraga, Shukuko Yoshida, Yoichi Kakuta, Hidezumi Kikuchi, Shogo Kawaguchi, Keisuke Hasui, Tetsuya Tatsuta, Daisuke Chinda, Tatsuya Mikami, Shinsaku Fukuda
Intestinal Research.2022; 20(1): 90. CrossRef A direct sequencing assay for pharmacogenetic testing of thiopurine-intolerant NUDT15 alleles in an Asian population
Kok-Siong Poon, Izz Irfan B. Imran, Silvester Kheng-Han Chew, Patrice Tan, Karen Mei-Ling Tan
BMC Research Notes.2022;[Epub] CrossRef Use of Azathioprine in Ulcerative Colitis: A Comprehensive Review
Bipadabhanjan Mallick, Sarthak Malik
Cureus.2022;[Epub] CrossRef Personalized medicine in inflammatory bowel disease: Perspectives on Asia
Su Hyun Park, Sang Hyoung Park
Journal of Gastroenterology and Hepatology.2022; 37(8): 1434. CrossRef Is Monitoring of the Intracellular Active Metabolite Levels of Nucleobase and Nucleoside Analogs Ready for Precision Medicine Applications?
Shenjia Huang, Yicong Bian, Chenrong Huang, Liyan Miao
European Journal of Drug Metabolism and Pharmacokinetics.2022; 47(6): 761. CrossRef Updates on conventional therapies for inflammatory bowel diseases: 5-aminosalicylates, corticosteroids, immunomodulators, and anti-TNF-α
Jihye Park, Jae Hee Cheon
The Korean Journal of Internal Medicine.2022; 37(5): 895. CrossRef Implementation of NUDT15 Genotyping to Prevent Azathioprine‐Induced Leukopenia for Patients With Autoimmune Disorders in Chinese Population
Chuang‐Wei Wang, Min‐Hui Chi, Tsen‐Fang Tsai, Kuang‐Hui Yu, Hsiao‐Wen Kao, Hsiang‐Cheng Chen, Chun‐Bing Chen, Chun‐Wei Lu, Wei‐Ti Chen, Ya‐Ching Chang, Chih‐Jung Chang, Yun‐Ting Chang, Yeong‐Jian Jan Wu, Chee‐Jen Chang, Yu Huei Huang, Chau‐Yee Ng, Po‐Wei
Clinical Pharmacology & Therapeutics.2022; 112(5): 1079. CrossRef Monotherapy with thiopurines in stricturing Crohn’s disease: A real-life experience from low- and middle-income countries
Bhaskar Kante, Sudheer Kumar Vuyyuru, Saurabh Kedia, Pabitra Sahu, Peeyush Kumar, Mukesh Kumar Ranjan, Shubi Virmani, Raju Sharma, Kumble Seetharama Madhusudhan, Rajesh Panwar, Prasenjit Das, Govind Makharia, Vineet Ahuja
Indian Journal of Gastroenterology.2022; 41(4): 343. CrossRef Personalized medicine to implementation science: Thiopurines set for the leap
Vishal Sharma, Saurabh Kedia, Vineet Ahuja
JGH Open.2022; 6(10): 651. CrossRef Natural history of inflammatory bowel disease: a comparison between the East and the West
Eun Mi Song, Suk-Kyun Yang
Intestinal Research.2022; 20(4): 418. CrossRef Prevalence of polymorphisms in thiopurine metabolism and association with adverse outcomes: a South Asian region-specific systematic review and meta-analysis
Anuraag Jena, Daya Krishna Jha, Praveen Kumar-M, Kripa Shanker Kasudhan, Ankit Kumar, Dhruv Sarwal, Shubhra Mishra, Anupam Kumar Singh, Prateek Bhatia, Amol Patil, Vishal Sharma
Expert Review of Clinical Pharmacology.2021; 14(4): 491. CrossRef Clinical characteristics of ulcerative colitis in elderly patients
Mingming Zhu, Zhihua Ran
JGH Open.2021; 5(8): 849. CrossRef TPMT and NUDT15 polymorphisms in thiopurine induced leucopenia in inflammatory bowel disease: a prospective study from India
Narinder Grover, Prateek Bhatia, Antriksh Kumar, Minu Singh, Deepesh Lad, Harshal S. Mandavdhare, Jayanta Samanta, Kaushal K. Prasad, Usha Dutta, Vishal Sharma
BMC Gastroenterology.2021;[Epub] CrossRef Current status of inflammatory bowel diseases in Korea
Suk-Kyun Yang
Journal of the Korean Medical Association.2021; 64(9): 572. CrossRef Treatment of inflammatory bowel diseases: focusing on 5-aminosalicylates and immunomodulators
You Sun Kim
Journal of the Korean Medical Association.2021; 64(9): 596. CrossRef Pharmacogenetics-based personalized treatment in patients with inflammatory bowel disease: A review
Ji Young Chang, Jae Hee Cheon
Precision and Future Medicine.2021; 5(4): 151. CrossRef
|